Lv31
208 积分 2025-04-28 加入
Cardiometabolic and renal benefits of sodium–glucose cotransporter 2 inhibitors
5小时前
待确认
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
12天前
已完结
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
12天前
已完结
Aldosterone synthase inhibition in chronic kidney disease
12天前
已完结
Targeting RNA with small molecules, from RNA structures to precision medicines: IUPHAR review: 40
12天前
已完结
How multispecific molecules are transforming pharmacotherapy
1个月前
已完结
China rheumatoid arthritis registry of patients with Chinese medicine (CERTAIN): Rationale, design, and baseline characteristics of the first 11,764 enrollees
2个月前
已完结
Prevalence of obesity and associated complications in China: A cross‐sectional, real‐world study in 15.8 million adults
2个月前
已完结
PROTACs, molecular glues and bifunctionals from bench to bedside: Unlocking the clinical potential of catalytic drugs
2个月前
已完结
Mechanisms controlling cellular and systemic iron homeostasis
2个月前
已完结
皖公网安备34019202002308
